Deena Beasley

Selected news for Deena Beasley, representing 2% of data collected since 10/2017. Recent stories appear in Yahoo News and hot96.com. This person shares healthcare news with Gilead, COVID-19, Gilead Sciences, Food and Drug Administration and dozens of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
12/30/2020 Exclusive-Dialysis Clinics Provide New Path for Delivery of Stockpiled COVID-19 Antibody Drugs in U.S. U.S. News & World Report ... 9:43 a.m. FILE PHOTO: Healthcare workers treat patients infected with the coronavirus disease (COVID-19) at United Memorial Medical Center in Houston, Texas, U.S., December 28, 2020. REUTERS/Callaghan O'Hare/File Photo ReutersBy Deena Beasley (Reuters) - Dialysis centers in the United States are rolling out COVID-19 antibody treatments this week, a new path for delivery of Eli Lilly and Regeneron drugs approved for emergency use but facing skepticism ...
12/16/2020 U.S. Hospital Demand for Lilly, Regeneron COVID-19 Antibody Drugs 'Disappointing' U.S. News & World Report ... Service Content Dec. 16, 2020, at 3:34 p.m. FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake ReutersBy Deena Beasley (Reuters) - U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said ...
12/16/2020 U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs ‘disappointing’ kwsn.com U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs ‘disappointing’ 2:34 PMBy Deena Beasley (Reuters) - U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said on Wednesday.Demand for the therapies, which are given as a one-time intravenous infusion, has been "disappointing," and ...
12/16/2020 U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs 'disappointing' Yahoo News By Deena Beasley (Reuters) - U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said on Wednesday.Demand for the therapies, which are given as a one-time intravenous infusion, has been "disappointing," and hospitals should be using them more, Operation Warp Speed chief advisor Dr. Moncef Slaoui ...
12/16/2020 U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs ‘disappointing’ jackfmfargo.com U.S. hospital demand for Lilly, Regeneron COVID-19 antibody drugs ‘disappointing’ 2:34 PMBy Deena Beasley (Reuters) - U.S. hospitals have been slow to embrace COVID-19 antibody drugs from Eli Lilly and Co and Regeneron Pharmaceuticals Inc that have been authorized to reduce the risk of hospitalization, U.S. officials said on Wednesday.Demand for the therapies, which are given as a one-time intravenous infusion, has been "disappointing," and ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll hi99.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll Terre Haute, IN, USA / WTHI HI-99 Dec 11, 2020 12:08 AMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll hot96.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll / HOT 96 Today's Hit Music Evansville, IN Dec 10, 2020 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll wtbx.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll Hibbing, MN, USA / 93.9 WTBX Dec 10, 2020 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll wtvbam.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll 11, 2020 12:08 AMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll kwsn.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll / Sports Radio KWSN Dec 10, 2020 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll froggyweb.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge to efforts ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll 941theduke.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll 11, 2020 12:08 AMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll krro.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge to efforts ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters/Ipsos poll dukefmfargo.com More women than men in U.S. nervous about fast rollout of COVID vaccine, and that’s a problem: Reuters/Ipsos poll / KMJO 104.7 Duke FM Dec 10, 2020 11:08 PMBy Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos ...
12/11/2020 More women than men in U.S. nervous about fast rollout of COVID vaccine, and that's a problem: Reuters poll Yahoo News By Chris Kahn and Deena Beasley NEW YORK (Reuters) - American women, who traditionally make most of the healthcare decisions in their families, are more wary than men of the new, rapidly developed COVID-19 vaccines, according to a Reuters/Ipsos poll, presenting a potential challenge to efforts to immunize the public.The Dec. 2-8 national opinion survey showed that 35% of women said they were “not very” or “not ...